Cargando…

Inhibition of Soluble Epoxide Hydrolase Does Not Promote or Aggravate Pulmonary Hypertension in Rats

Inhibitors of soluble epoxide hydrolase (sEH), which catalyzes the hydrolysis of various natural epoxides to their corresponding diols, present an opportunity for developing oral drugs for a range of human cardiovascular and inflammatory diseases, including, among others, diabetes and neuropathic pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leuillier, Matthieu, Platel, Valentin, Tu, Ly, Feugray, Guillaume, Thuillet, Raphaël, Groussard, Déborah, Messaoudi, Hind, Ottaviani, Mina, Chelgham, Mustapha, Nicol, Lionel, Mulder, Paul, Humbert, Marc, Richard, Vincent, Morisseau, Christophe, Brunel, Valéry, Duflot, Thomas, Guignabert, Christophe, Bellien, Jérémy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954493/ https://www.ncbi.nlm.nih.gov/pubmed/36831332 http://dx.doi.org/10.3390/cells12040665

Ejemplares similares

Preventing the Increase in Lysophosphatidic Acids: A New Therapeutic Target in Pulmonary Hypertension?
por: Duflot, Thomas, et al.
Publicado: (2021)

CRISPR/Cas9-mediated inactivation of the phosphatase activity of soluble epoxide hydrolase prevents obesity and cardiac ischemic injury
por: Leuillier, Matthieu, et al.
Publicado: (2022)

The Metabolism of Epoxyeicosatrienoic Acids by Soluble Epoxide Hydrolase Is Protective against the Development of Vascular Calcification
por: Varennes, Olivier, et al.
Publicado: (2020)

Editorial: Clinical Paths for Soluble Epoxide Hydrolase Inhibitors
por: Imig, John D., et al.
Publicado: (2020)

Soluble Epoxide Hydrolase Inhibition Prevents Experimental Type 4 Cardiorenal Syndrome
por: Hamzaoui, Mouad, et al.
Publicado: (2021)

Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors
por: Kodani, Sean D., et al.
Publicado: (2018)

Effects of Individual Circulating FFAs on Plasma and Hepatic FFA Epoxides, Diols, and Epoxide-Diol Ratios as Indices of Soluble Epoxide Hydrolase Activity
por: Oh, Young Taek, et al.
Publicado: (2023)

Inhibition of the Soluble Epoxide Hydrolase as an Analgesic Strategy: A Review of Preclinical Evidence
por: Wang, Yuxin, et al.
Publicado: (2021)

Soluble Epoxide Hydrolase Deletion Limits High-Fat Diet-Induced Inflammation
por: Wagner, Karen M., et al.
Publicado: (2021)

Effects of Soluble Epoxide Hydrolase Deficiency on Acute Pancreatitis in Mice
por: Bettaieb, Ahmed, et al.
Publicado: (2014)

Occurrence of urea-based soluble epoxide hydrolase inhibitors from the plants in the order Brassicales
por: Kitamura, Seiya, et al.
Publicado: (2017)

Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis
por: McReynolds, Cindy B., et al.
Publicado: (2019)

Effect of Soluble Epoxide Hydrolase on the Modulation of Coronary Reactive Hyperemia: Role of Oxylipins and PPARγ
por: Hanif, Ahmad, et al.
Publicado: (2016)

Soluble Epoxide Hydrolase Is Associated with Postprandial Anxiety Decrease in Healthy Adult Women
por: Nguyen, Nhien, et al.
Publicado: (2022)

The Generation of a Nanobody-Based ELISA for Human Microsomal Epoxide Hydrolase
por: He, Qiyi, et al.
Publicado: (2023)

Pharmacological Inhibition of Soluble Epoxide Hydrolase Ameliorates Diet-Induced Metabolic Syndrome in Rats
por: Iyer, Abishek, et al.
Publicado: (2012)

Soluble Epoxide Hydrolase Contributes to Cell Senescence and ER Stress in Aging Mice Colon
por: Wang, Weicang, et al.
Publicado: (2023)

Selection of Potent Inhibitors of Soluble Epoxide Hydrolase for Usage in Veterinary Medicine
por: Shihadih, Diyala S., et al.
Publicado: (2020)

Relative Importance of Soluble and Microsomal Epoxide Hydrolases for the Hydrolysis of Epoxy-Fatty Acids in Human Tissues
por: Morisseau, Christophe, et al.
Publicado: (2021)

Soluble Epoxide Hydrolase Hepatic Deficiency Ameliorates Alcohol-Associated Liver Disease
por: Mello, Aline, et al.
Publicado: (2020)

Dysregulation of Soluble Epoxide Hydrolase and Lipidomic Profiles in Anorexia Nervosa
por: Shih, Pei-an Betty, et al.
Publicado: (2015)

Evaluation of fish models of soluble epoxide hydrolase inhibition.
por: Newman, J W, et al.
Publicado: (2001)

Ibuprofen alters epoxide hydrolase activity and epoxy-oxylipin metabolites associated with different metabolic pathways in murine livers
por: Tiwari, Shuchita, et al.
Publicado: (2021)

Aflatoxin B(1) Increases Soluble Epoxide Hydrolase in the Brain and Induces Neuroinflammation and Dopaminergic Neurotoxicity
por: Wang, Weicang, et al.
Publicado: (2023)

Quantification of soluble epoxide hydrolase inhibitors in experimental and clinical samples using the nanobody-based ELISA
por: Yang, Huiyi, et al.
Publicado: (2023)

Screening and Biological Evaluation of Soluble Epoxide Hydrolase Inhibitors: Assessing the Role of Hydrophobicity in the Pharmacophore-Guided Search of Novel Hits
por: Vázquez, Javier, et al.
Publicado: (2023)

The Role of Hydrolases in Biology and Xenobiotics Metabolism
por: Morisseau, Christophe
Publicado: (2022)

Inhibition of the Soluble Epoxide Hydrolase Promotes Albuminuria in Mice with Progressive Renal Disease
por: Jung, Oliver, et al.
Publicado: (2010)

2-(Piperidin-4-yl)acetamides as Potent Inhibitors of Soluble Epoxide Hydrolase with Anti-Inflammatory Activity
por: Martín-López, Juan, et al.
Publicado: (2021)

Development of an online SPE–LC–MS-based assay using endogenous substrate for investigation of soluble epoxide hydrolase (sEH) inhibitors
por: Schebb, Nils Helge, et al.
Publicado: (2011)

Soluble epoxide hydrolase inhibitor, TPPU, increases regulatory T cells pathway in an arthritis model
por: Trindade‐da‐Silva, Carlos A., et al.
Publicado: (2020)

Pulmonary hypertension associated with neurofibromatosis type 2
por: Taniguchi, Hirohisa, et al.
Publicado: (2021)

Arsenic trioxide demonstrates efficacy in a mouse model of preclinical systemic sclerosis
por: Cauvet, Anne, et al.
Publicado: (2023)

Potent Natural Soluble Epoxide Hydrolase Inhibitors from Pentadiplandra brazzeana Baillon: Synthesis, Quantification, and Measurement of Biological Activities In Vitro and In Vivo
por: Kitamura, Seiya, et al.
Publicado: (2015)

Effect of a Soluble Epoxide Hydrolase Inhibitor, UC1728, on LPS-Induced Uveitis in the Rabbit
por: McLellan, Gillian J., et al.
Publicado: (2016)

Soluble Epoxide Hydrolase in Atherosclerosis
por: Wang, Yi-Xin Jim, et al.
Publicado: (2010)

Epoxide Hydrolases: Multipotential Biocatalysts
por: Bučko, Marek, et al.
Publicado: (2023)

Soluble Epoxide Hydrolase Inhibition by t-TUCB Promotes Brown Adipogenesis and Reduces Serum Triglycerides in Diet-Induced Obesity
por: Overby, Haley, et al.
Publicado: (2020)

Differential Effects of 17,18-EEQ and 19,20-EDP Combined with Soluble Epoxide Hydrolase Inhibitor t-TUCB on Diet-Induced Obesity in Mice
por: Yang, Yang, et al.
Publicado: (2021)

Determination of Lipoxygenase, CYP450, and Non-Enzymatic Metabolites of Arachidonic Acid in Essential Hypertension and Type 2 Diabetes
por: Feugray, Guillaume, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e475of0q8rf9fjrvmk5dtr7t5r